Medicine recalls
|
| |
| Australia: Apotex-Pantoprazole 40 mg tablets: Recall - potential missing blister sheets |
| |
Consumers and health professionals are advised that Apotex, in consultation with the Therapeutic Goods Administration (TGA), is recalling one batch of Apotex-Pantoprazole 40 mg tablets (batch number F4442, expiry date 10/2018).
It has been identified that this medicine may have been dispensed with missing blister sheets, which means affected packs would not contain the correct amount of tablets.
Apotex-Pantoprazole 40 mg tablets belong to a group of medicines called proton pump inhibitors (PPIs). PPIs work by decreasing the amount of acid the stomach makes, to give relief from the symptoms of ulcers, reflux disease and Zollinger-Ellison syndrome, and allow healing to take place.
Apotex has written to pharmacists providing further information about this issue, including details of the recall process.
Consumers are advised to return any unused medicine to their pharmacies for a refund and/or to arrange alternative medicine if they have a pack that has been affected by this issue.
Health professionals are advised to inspect their stocks and quarantine all packs from the affected batch before returning them to their wholesalers.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/apotex-pantoprazole-40-mg-tablets
In Hong Kong, there is a registered tablet containing active ingredient of pantoprazole 40mg per tablet under the brand name APO-PANTOPRAZOLE TAB 40MG (HK59280), manufactured by APOTEX INC. in CANADA The product is registered by HIND WING CO LTD (Hind Wing) and is a prescription only medicine. As confirmed with Hind Wing, the recall in Australia has no impact on the products marketed in Hong Kong.
Ends/ Saturday, May 27, 2017
Issued at HKT 12:00
Content last updated: Monday, May 29, 2017
|
| |
